KRILL'ALGIC
Food supplement declared in France, declaration No 2021-7-711
KRILL'ALGIC is a food supplement declared in France. Status: retrait du marché annoncé pour le 27 May 2029. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- New Stefal Holding
- Status
- Retrait du marché annoncé pour le 27 May 2029
- Form
- Capsule
- Daily dose
- 2 capsules
- Directions for use
- Prendre 2 capsules par jour au milieu du repas avec un grand verre d’eau.
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes, Utilisation prolongée
- Objectives stated by the manufacturer (these are not authorised claims)
- Articulations
Declaration 177385, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 27 May 2029, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Bambusa bambos (L.) Voss | Exsudat | Extrait sec aqueux | 60 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Huile de Krill | not declared |
| Huile de poisson | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Sulfate de manganèse | Manganèse | 8 mg (niveau de sécurité) | 3.5 mg |
| Sélénate de sodium | Sélénium | 255 µg | 50 µg |
Additives
E422, E172, E901, E420
Other ingredients
gélatine, Eau potable, huile de tournesol
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne convient pas aux femmes enceintes ou qui allaitent. Un usage prolongé est déconseillé.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- KRILL'ALGIC New Stefal Holding, declared in 2019, withdrawn from the market : different composition: 1 ingredient(s) added, 1 missing
- KRILL'ALGIC PHYDERMA PARIS, declared in 2018, withdrawn from the market : different composition: 1 ingredient(s) added, 2 missing